生物活性 | |||
---|---|---|---|
描述 | PKSI-527, a novel and highly selective inhibitor of plasma kallikrein, can mitigate collagen-induced arthritis (CIA) through alterations in the kallikrein-kinin system[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.11mL 0.42mL 0.21mL |
10.55mL 2.11mL 1.05mL |
21.10mL 4.22mL 2.11mL |
参考文献 |
---|